87 GHP Healthcare & Pharma Awards 2023 Spark Biomedical is dedicated to working towards a world free from opioid addiction. Its intention is to eliminate the misuse of such drugs by addressing the worldwide opioid addiction lifecycle, and pushing the boundaries of science and technology to unravel the problem in its entirety. Its solution is a wearable product designed to treat opioid withdrawal symptoms. Using opioids to treat legitimate pain sometimes has the unfortunate side effect of creating a dependency that is difficult to break. This can result in a drug addiction like any other, and has led to a world in the grip of opioid dependency. The curse of trying to free oneself from such an opioid addiction has thus far meant a hard choice between going cold turkey, or taking more opioids. Sadly, there is a terrific 80% relapse rate in the first month, as people find the effects just too hard to bear. Founded in 2018, the Dallas, Texas based medical equipment manufacturing company Spark Biomedical is here to change things for the better. It specialises in neuromodulation and medical devices, and has found a third way to treat opioid withdrawal symptoms. It has brought to market the Sparrow Ascent®, specifically for the relief of opioid withdrawal symptoms. The Sparrow Ascent is a wearable treatment technology, designed to make it easier for people to overcome withdrawal symptoms, heal from addiction, and be free to achieve the life they deserve to live. The Sparrow Ascent is a safe, non-addictive treatment option with no known drug interactions or systemic side effects, and no diversion risk. It is a comfortable piece of wearable kit, with no need for users to have to experience withdrawal before commencing treatment. Each patient is in control of their therapy throughout treatment, and it can be carried out in-patient/out-patient, at home, at work, or on the go. The Sparrow Ascent is drug free, operating by use of mild electrical pulses instead of pills. There are no daily clinic visits required for the treatment, and the patient can control their own sobriety date. It’s the only FDA cleared, drug-free, non-addictive, and non-invasive wearable treatment technology for the relief of opioid withdrawal symptoms. It’s a next-generation product, designed for more versatile patient use. The starter kit comes complete with 28 lightweight and flexible earpieces, to help address the prolonged withdrawal experience seen with the prevalence of fentanyl. The disposable earpieces are as easy to apply as a sticker, and deliver mild electrical stimulation to the nerves on and around the ear. The supplied cable connects and delivers these electrical impulses from the patient controller to the earpiece. The patient controller delivery system allows each patient to take control of the pain relief level appropriate to them. The colour LCD screen provides at-a-glance information on the ongoing therapeutic use of the equipment. The Sparrow Ascent non-invasive, wearable neurostimulation device for opioid addiction withdrawal relief is backed by a Level 1 clinical trial. It’s been proven to provide significant relief from opioid withdrawal symptoms in as little as 30 minutes. With no pills, and no needles, the results achieved by the Sparrow Ascent are remarkable. From a panel of 31 patients suffering from opioid withdrawal symptoms, a huge 84% of 9 out of 10 participants who completed detox accepted a referral to continue substance use disorder treatment. 100% sustained a clinically meaningful reduction in symptoms by day 3, and 93% hoped to continue using the treatment method after the trial. Another positive outcome was that a significant percentage of those taking part in the clinical trial experienced a reduction in symptoms of depression and PTSD, further helping to bolster the recovery journey. The company has also been delighted to receive feedback from medical professionals who value the difference this wearable technology is making for their patients. For example, Carlos Tirado, MD, MPH, an expert in addiction treatment at CarmaHealth commented, “So happy to know that we’ve been able to get this in the hands of providers in treatment centers! Opens up possibilities for transition to opioid blockade in those who choose this medication pathway.” On a similar note, Michael Spintz, DO, FMASAM, a triple boardcertified expert in addiction and chronic pain, comments, “Finally I have another option that gets my patients safely and effectively through opioid addiction…” It’s fantastic to see that this incredible company has been recognised for its terrific work with the title Best Wearable Neurostimulation Solutions Developer 2023. This outstanding company truly deserves the commendation for its important healthcare innovations. Company: Spark Biomedical Web Address: https://www.sparrowrx.com/ Contact Name: Jackie Powell Best Wearable Neurostimulation Solutions Developer 2023 Jul23235
RkJQdWJsaXNoZXIy MTUyMDQwMA==